|27.02||-0.38 / -1.39%|
Data as of 4:00pm ET
|27.02||0.00 / 0.00%|
The 3 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 40.00, with a high estimate of 52.00 and a low estimate of 38.00. The median estimate represents a +48.04% increase from the last price of 27.02.
The current consensus among 4 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.